Aspen Pharmacare Holdings Ltd
Company Profile
Business description
Aspen Pharmacare Holdings Ltd is a specialty pharmaceutical company with a commercial footprint covering more than 50 countries and complex manufacturing capabilities in both API and finished dose form. The company focuses on a broad range of post-patent, branded medicines and domestic brands spanning many therapeutic areas. The company has four business segments such as Active Pharmaceutical Ingredients (API) – this segment includes the API Chemicals business and non-heparin biochemical API business, Heparin – this segment includes the full value chain contribution from all heparin containing products including API and Finished Dose. Form (FDF) sales Key products include the Fraxiparine and MonoEmbolex heparin containing FDF products and FDF Steriles segment.
Contact
Douglas Saunders Drive
Aspen Place
9 Rydall Vale Park
La Lucia Ridge
DurbanNL
ZAFT: +27 315808600
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
30 June 2025
Employees
9,350
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,148.90 | 93.60 | 1.16% |
CAC 40 | 8,094.20 | 77.27 | -0.95% |
DAX 40 | 22,999.15 | 288.91 | -1.24% |
Dow JONES (US) | 41,953.32 | 11.31 | -0.03% |
FTSE 100 | 8,701.99 | 4.67 | -0.05% |
HKSE | 24,219.95 | 551.19 | -2.23% |
NASDAQ | 17,691.63 | 59.16 | -0.33% |
Nikkei 225 | 37,751.88 | 93.54 | -0.25% |
NZX 50 Index | 12,107.95 | 53.23 | 0.44% |
S&P 500 | 5,662.89 | 12.40 | -0.22% |
S&P/ASX 200 | 7,918.90 | 90.60 | 1.16% |
SSE Composite Index | 3,408.95 | 17.48 | -0.51% |